BD (BDX) Signs to Acquire PhaSeal Maker Carmel Pharma
Tweet
Share
E-mail
Up)
BD (Becton, Dickinson and Company) (NYSE: BDX) has entered an agreement to acquire Carmel Pharma, Inc.
The acquisition is expected to close by the end of BD's fiscal year 2011. The financial terms of the agreement were not disclosed.
Carmel Pharma manufactures the PhaSeal System, the leading closed-system drug transfer device for the safe handling of hazardous drugs that are packaged in vials.
The acquisition is expected to close by the end of BD's fiscal year 2011. The financial terms of the agreement were not disclosed.
Carmel Pharma manufactures the PhaSeal System, the leading closed-system drug transfer device for the safe handling of hazardous drugs that are packaged in vials.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Capri Holdings Limited (CPRI) Statement on FTC Action Seeking over Tapestry Deal
- Oportun Financial Corporation (OPRT) Appoints Scott Parker to its Board
- Wolfspeed pops as activist investor urges firm to consider options, including sale
Create E-mail Alert Related Categories
Corporate News, FDA, Mergers and AcquisitionsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
